Curasight A/S announced the achievement of the first milestone under the agreement with Curium inc., to develop Curasight’s uTRACE® PET imaging technology for the improved diagnosis of prostate cancer.
Curasight A/S announced the achievement of the first milestone under the agreement with Curium inc., to develop Curasight’s uTRACE® PET imaging technology for the improved diagnosis of prostate cancer.